WeChat Mini Program
Old Version Features

Obinutuzumab and Minichop for Unfit Patients with Diffuse Large B-cell Lymphoma. A Phase II Study by Fondazione Italiana Linfomi.

F. Merli,S. Luminari,F. Salvi,F. Cavallo,G. Gini,G. Musuraca,G. Gaidano,C. Cellini,M. Merli,A. Ferrari,A. Molinari,A. M. Liberati,A. Conconi,P. Matteucci,S. Pozzi,M. Musso,C. Mammi,F. Monaco,S. Ferrero,A. Tucci

Hematological Oncology（2017）

Cited 19|Views126
Key words
Diffuse large B-cell lymphoma,Older adult patients,Comprehensive geriatric assessment,Unfit,Adapted immunochemotherapy,Obinutuzumab-miniCHOP
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined